Skip to main content

Tom Brady-backed telehealth AI startup eMed raises $200M, tops $2B valuation

The company will use the funds to expand its agentic AI platform and fund new models for employers, including access to GLP-1 medications.
By Jessica Hagen , Executive Editor
NFL player Tom Brady

Former NFL quarterback and current eMed Chief Wellness Officer Tom Brady

Photo: Ron Jenkins/Getty Images

Telehealth and digital health company eMed, whose founding chief wellness officer is former NFL quarterback Tom Brady, has closed a $200 million Series A funding round at a more than $2 billion valuation.

AON Consulting participated in the round alongside Brady; former X CEO and current eMed CEO Linda Yaccarino; Jeff Aronin, founder, chairman and CEO of Paragon Biosciences; Ara Cohen, cofounder and comanaging member of Knighthead Capital Management; and Antonio Gracias, founder and CEO of Valor Equity Partners.

Joe Lonsdale, founder and managing partner at 8VC and cofounder of Palantir; R.J. Melman, CEO of Lettuce Entertain You Restaurants; and Tom Ricketts, chairman of the Chicago Cubs, also participated in the round.  

WHAT IT DOES

eMed offers an individual and employee health benefit platform with access to ongoing support, including GLP-1 medications, at-home blood testing and a care package for common side effects of GLP-1s.

The Miami-based company partners with employers to offer access to GLP-1s alongside ongoing clinical support. eMed touts its offering as a structured, clinically supported program for population health.

The company will use the financing to further enhance its agentic AI platform and boost its balance sheet to support the launch of a new capitated care model focused on helping employers expand access to GLP-1s.

"I believe eMed's empathic agentic AI platform, combined with the strength of its people and partners, represents a true winning formula. That conviction is why I've chosen to invest both my time as founding chief wellness officer and my capital in the company," Brady said in a statement.

MARKET SNAPSHOT

In 2023, London-based multinational digital health firm Babylon sold almost all of its UK assets to eMed Healthcare U.K., a subsidiary of U.S. company eMed.

Babylon Healthcare Services Limited, the piece of Babylon purchased by eMed and the bulk of what remained of Babylon Health, included a UK-based telehealth practice focused on preventative care that contracts with healthcare providers.

Brady has his own digital health company, TB12, which offers digital coaching, personalized training and health guidance, and nutrition and recovery products.

Another celebrity who is a big investor in the digital health space is tennis player and venture capitalist Serena Williams.

Williams has invested in Lifeforce, a personalized healthcare platform based on a telehealth model, and in virtual and in-office healthcare provider Juno Medical. She has also funded virtual women's health clinic Midi Health and pregnancy and postpartum care company Mahmee.